bcr_patient_uuid	bcr_patient_barcode	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	clinical_trial_indicator	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	pharmaceutical_tx_started_days_to	pharmaceutical_tx_ongoing_indicator	pharmaceutical_tx_ended_days_to	treatment_best_response
bcr_patient_uuid	bcr_patient_barcode	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	tx_on_clinical_trial	drug_name	clinical_trail_drug_classification	therapy_type	days_to_drug_therapy_start	therapy_ongoing	days_to_drug_therapy_end	measure_of_response
CDE_ID:	CDE_ID:2673794	CDE_ID:	CDE_ID:	CDE_ID:	CDE_ID:2503808	CDE_ID:2975232	CDE_ID:3378323	CDE_ID:2793530	CDE_ID:3392465	CDE_ID:3103479	CDE_ID:3392470	CDE_ID:2857291
83b3060c-2449-4581-88ef-817d126e4525	TCGA-KL-8323	TCGA-KL-8323-D33911	5EDBDBA5-8EE3-45E6-B0A5-5948DA3689A5	2012-7-24	NO	Lymphocyte Infusion	[Not Available]	Immunotherapy	880	NO	[Not Available]	[Unknown]
83b3060c-2449-4581-88ef-817d126e4525	TCGA-KL-8323	TCGA-KL-8323-D33912	69C8BF63-23C1-46D5-AFB8-7192AFB58760	2012-7-24	YES	PTK-ZK	[Not Available]	Targeted Molecular therapy	911	NO	942	[Unknown]
63643ba6-bed9-4c36-91dd-a18105fadc06	TCGA-KL-8336	TCGA-KL-8336-D33939	C706BEA1-7CC9-4D8A-ABCC-51DD05EFE077	2012-7-24	NO	Sunitinib	[Not Available]	Targeted Molecular therapy	138	NO	559	[Unknown]
63643ba6-bed9-4c36-91dd-a18105fadc06	TCGA-KL-8336	TCGA-KL-8336-D33940	6251213A-2CA9-4E23-BB20-356074A881A8	2012-7-24	NO	Temsirolimus	[Not Available]	Chemotherapy	558	NO	817	[Unknown]
63643ba6-bed9-4c36-91dd-a18105fadc06	TCGA-KL-8336	TCGA-KL-8336-D33941	74B0A250-2C27-49BB-9ED5-9E2994C6CF9A	2012-7-24	NO	Bevacizumab	[Not Available]	Chemotherapy	824	NO	838	[Unknown]
e0e38071-877f-4ebf-955f-483eb4865351	TCGA-KL-8339	TCGA-KL-8339-D32704	C00D326B-2D48-4084-9F21-5C04D5E27BC9	2012-6-7	NO	Sunitinib	[Not Available]	Targeted Molecular therapy	111	NO	251	[Unknown]
70e306ee-9584-49d6-81a1-a49d837ab6aa	TCGA-KL-8341	TCGA-KL-8341-D33919	6463DA70-D7C2-4BB5-84E9-6C5AACDD0E94	2012-7-24	YES	Sunitinib	[Not Available]	Targeted Molecular therapy	196	NO	366	[Unknown]
70e306ee-9584-49d6-81a1-a49d837ab6aa	TCGA-KL-8341	TCGA-KL-8341-D33923	AC4D913B-061E-41B9-A504-8E63C9A93D00	2012-7-24	NO	Sunitinib	[Not Available]	Targeted Molecular therapy	397	NO	457	[Unknown]
70e306ee-9584-49d6-81a1-a49d837ab6aa	TCGA-KL-8341	TCGA-KL-8341-D33924	E922EBC8-97A1-4B90-8D38-5CDD480BE0D5	2012-7-24	NO	Temsirolimus	[Not Available]	Chemotherapy	567	NO	609	[Unknown]
70e306ee-9584-49d6-81a1-a49d837ab6aa	TCGA-KL-8341	TCGA-KL-8341-D33925	6C137653-E683-420B-B63B-F2C57B064041	2012-7-24	NO	Sorafenib	[Not Available]	Targeted Molecular therapy	624	NO	[Not Available]	[Unknown]
23656226-2d99-4548-959f-5c2eed803e33	TCGA-KM-8438	TCGA-KM-8438-D32859	1574D627-CF11-42BA-94C3-3F5854A4C649	2012-6-14	NO	Sutent	[Not Available]	Targeted Molecular therapy	2342	NO	2731	[Unknown]
23656226-2d99-4548-959f-5c2eed803e33	TCGA-KM-8438	TCGA-KM-8438-D32860	2D6C5401-74D1-4080-B9FD-8C94D19C5A99	2012-6-14	NO	Temsirolimus	[Not Available]	Targeted Molecular therapy	2731	NO	4436	[Unknown]
23656226-2d99-4548-959f-5c2eed803e33	TCGA-KM-8438	TCGA-KM-8438-D32861	6442C5A4-A38C-487D-95A2-9BD3EB249787	2012-6-14	NO	Bevacizumab	[Not Available]	Targeted Molecular therapy	3554	NO	3858	[Unknown]
8D30C7BE-73B6-4C4C-80C5-31152B2F7CB0	TCGA-KM-A7Q8	TCGA-KM-A7Q8-D62492	3789FA17-816C-4768-A1FE-E8E49373B5BC	2014-7-21	NO	Sunitinib	[Not Available]	Targeted Molecular therapy	[Not Available]	NO	[Not Available]	Clinical Progressive Disease
b08dfba8-6afb-4217-9259-72be6f1f3363	TCGA-KN-8426	TCGA-KN-8426-D34188	36E267F1-1DC3-404E-830B-B58767C04AA0	2012-8-10	NO	Avastin	[Not Available]	Targeted Molecular therapy	[Not Available]	NO	[Not Available]	[Unknown]
b08dfba8-6afb-4217-9259-72be6f1f3363	TCGA-KN-8426	TCGA-KN-8426-D39303	6330F707-EA10-4F3C-916C-3C0292CD7E85	2013-1-16	NO	Sorafenib	[Not Available]	Targeted Molecular therapy	[Not Available]	NO	[Not Available]	[Unknown]
455fd7d4-5ff4-423f-83ce-4630aef89bb7	TCGA-KN-8428	TCGA-KN-8428-D34187	FD53289F-BFB3-419C-A907-26053E04B068	2012-8-17	NO	sorafenib	[Not Available]	Targeted Molecular therapy	510	NO	638	Clinical Progressive Disease
A86C2490-37DA-46A3-88E2-0B0CE21D067F	TCGA-UW-A7GR	TCGA-UW-A7GR-D54190	5B20A89E-1F30-4D80-B29F-F57E09B5BA9E	2013-12-17	YES	Interferon	[Not Available]	Immunotherapy	22	NO	288	Partial Response
A86C2490-37DA-46A3-88E2-0B0CE21D067F	TCGA-UW-A7GR	TCGA-UW-A7GR-D54191	3237FFE4-790D-4C54-8F2B-F5B75B60D901	2013-12-17	YES	Sorafenib	[Not Available]	Chemotherapy	22	NO	288	Partial Response
